WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001082902) METHOD AND COMPOSITION FOR RAPID DELIVERY OF BIOACTIVE COMPOUNDS TO THE SYSTEMIC CIRCULATION VIA THE NASAL MEMBRANE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/082902    International Application No.:    PCT/US2001/013973
Publication Date: 08.11.2001 International Filing Date: 30.04.2001
Chapter 2 Demand Filed:    20.11.2001    
IPC:
A61K 9/00 (2006.01), A61K 9/127 (2006.01), A61K 31/685 (2006.01), A61K 31/715 (2006.01), A61K 38/12 (2006.01), A61K 38/28 (2006.01), A61K 38/34 (2006.01)
Applicants: ZENGEN, INC. [US/US]; 21800 Oxnard Street Suite 980 Woodland Hills, CA 91367 (US) (For All Designated States Except US).
HENSLEY, Charles [US/US]; (US) (For US Only).
DAVIDSON, Robert, S. [US/US]; (US) (For US Only)
Inventors: HENSLEY, Charles; (US).
DAVIDSON, Robert, S.; (US)
Agent: WISE, Michael, J.; Lyon & Lyon LLP Suite 4700 633 West Fifth Street Los Angeles, CA 90071-2066 (US)
Priority Data:
60/200,286 28.04.2000 US
Title (EN) METHOD AND COMPOSITION FOR RAPID DELIVERY OF BIOACTIVE COMPOUNDS TO THE SYSTEMIC CIRCULATION VIA THE NASAL MEMBRANE
(FR) PROCEDE ET COMPOSITION PERMETTANT UN APPORT RAPIDE DE COMPOSES BIOACTIFS AU SYSTEME CIRCULATOIRE VIA LA MEMBRANE NASALE
Abstract: front page image
(EN)A bioadhesive phosphomatrix composition and method for rapid delivery of effective amounts of active substances through the nasal membrane into the circulatory system. The composition may contain permeation enhancers that facilitate delivery of the active substance to the systemic circulation.
(FR)La présente invention concerne une composition phosphomatricielle bioadhésive et un procédé permettant un apport rapide de quantités efficaces de principes actifs à travers la membrane nasale dans le système circulatoire. Cette composition peut contenir des amplificateurs de perméance qui facilitent l'apport du principe actif au système circulatoire.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)